ACTIVE BIOMARKERS

Founded in 2011, Active Biomarkers is an integrated bioanalytical laboratory offering a wide range of in-vitro immunology services, including soluble and cellular biomarker analyses for preclinical and clinical studies. Operating in BSL2 facilities, and GLP/GCLP/ISO 9001:2015 environment, the company currently employs 32 scientists bringing a wealth of experience in the development, validation, and implementation of analytical methods. Its know-how is recognized in 4 major therapeutic areas: oncology, infectious diseases, inflammatory pathologies, and neurodegenerative diseases. Beyond its state-of-the-art flow cytometry and ELISpot capabilities, Active Biomarkers offers the broadest panel of immunoassay technologies in Europe, ranging from standard ELISA to multiplexed methods such as Luminex or ELLA systems, and ultra-sensitive technologies such as MSD or Simoa HD-X.